Organization
Array BioPharma Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Array BioPharma Inc.
... Levi & Korsinsky announces it has commenced an investigation of Array BioPharma Inc. ("Array BioPharma" or the "Company") (NASDAQ: ARRY) concerning possible violations of federal ...
... Array BioPharma Inc. (Nasdaq: ARRY) ("Array" or the "Company") announced today that it has entered ...
... Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... Editas Medicine, Inc. (NASDAQ: EDIT), Tenet Healthcare Corporation (NYSE: THC), Array BioPharma Inc. (NASDAQ: ARRY). Reliq Health Technologies Inc.(OTCQB: RQHTF) (TSX-V: RHT.V), a technology company ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will ...
... its position? What role will isatuximab have in the rrMM setting? Could Array BioPharma's filanesib, a KIF11 protein inhibitor, provide benefit in MM? KIF11protein provides ...
... BOULDER, Colo. - Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... If you want a Stock Review on FOLD, ARGS, ARRY, or AUPH then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will ...
... Array BioPharma Inc. (Nasdaq: ARRY) announced today the closing of its underwritten public offering of ...
... BOULDER, Colo. - Array BioPharma (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering ...
... Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced results from Part 2 of ...
... Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today announced safety results and initial clinical ...
... Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will ...
... the MAAs of binimetinib and encorafenib. If approved, the combination, co-developed with Array BioPharma, would represent a new and potentially important option for patients with ...
... Array BioPharma (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... BOULDER, Colo. - Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization ...
... If you want a Stock Review on OPK, ARRY, IMMU, or TGTX then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... for autoimmune disorders. The undisclosed target and lead inhibitors were discovered through Array's proprietary platform that leverages Array's expertise in chemistry and early lead development. ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤